JP2006522006A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522006A5
JP2006522006A5 JP2004536184A JP2004536184A JP2006522006A5 JP 2006522006 A5 JP2006522006 A5 JP 2006522006A5 JP 2004536184 A JP2004536184 A JP 2004536184A JP 2004536184 A JP2004536184 A JP 2004536184A JP 2006522006 A5 JP2006522006 A5 JP 2006522006A5
Authority
JP
Japan
Prior art keywords
unit dosage
modafinil
solid
solid modafinil
description
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004536184A
Other languages
English (en)
Japanese (ja)
Other versions
JP5039246B2 (ja
JP2006522006A (ja
Filing date
Publication date
Priority claimed from US10/660,058 external-priority patent/US20040116532A1/en
Application filed filed Critical
Publication of JP2006522006A publication Critical patent/JP2006522006A/ja
Publication of JP2006522006A5 publication Critical patent/JP2006522006A5/ja
Application granted granted Critical
Publication of JP5039246B2 publication Critical patent/JP5039246B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004536184A 2002-09-13 2003-09-12 モダフィニルの医薬製剤 Expired - Fee Related JP5039246B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41039502P 2002-09-13 2002-09-13
US60/410,395 2002-09-13
US10/660,058 US20040116532A1 (en) 2002-09-13 2003-09-11 Pharmaceutical formulations of modafinil
US10/660,058 2003-09-11
PCT/US2003/028651 WO2004024134A1 (en) 2002-09-13 2003-09-12 Pharmaceutical formulations of modafinil

Publications (3)

Publication Number Publication Date
JP2006522006A JP2006522006A (ja) 2006-09-28
JP2006522006A5 true JP2006522006A5 (cg-RX-API-DMAC7.html) 2006-11-24
JP5039246B2 JP5039246B2 (ja) 2012-10-03

Family

ID=32511269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004536184A Expired - Fee Related JP5039246B2 (ja) 2002-09-13 2003-09-12 モダフィニルの医薬製剤

Country Status (21)

Country Link
US (4) US20040116532A1 (cg-RX-API-DMAC7.html)
EP (1) EP1539126B1 (cg-RX-API-DMAC7.html)
JP (1) JP5039246B2 (cg-RX-API-DMAC7.html)
KR (1) KR101125462B1 (cg-RX-API-DMAC7.html)
CN (1) CN100528151C (cg-RX-API-DMAC7.html)
AU (1) AU2003267156B2 (cg-RX-API-DMAC7.html)
BR (1) BR0314514A (cg-RX-API-DMAC7.html)
CA (1) CA2498260C (cg-RX-API-DMAC7.html)
DK (1) DK1539126T3 (cg-RX-API-DMAC7.html)
EA (1) EA012964B1 (cg-RX-API-DMAC7.html)
ES (1) ES2392580T3 (cg-RX-API-DMAC7.html)
IL (1) IL167054A (cg-RX-API-DMAC7.html)
IS (1) IS2871B (cg-RX-API-DMAC7.html)
MX (1) MXPA05002827A (cg-RX-API-DMAC7.html)
NO (1) NO333614B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ538941A (cg-RX-API-DMAC7.html)
PL (1) PL375833A1 (cg-RX-API-DMAC7.html)
PT (1) PT1539126E (cg-RX-API-DMAC7.html)
SI (1) SI1539126T1 (cg-RX-API-DMAC7.html)
TW (1) TWI335217B (cg-RX-API-DMAC7.html)
WO (1) WO2004024134A1 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1309547E (pt) 2000-07-27 2007-03-30 Teva Pharma Modafinil cristalino e puro, e processo para a sua preparação
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
CA2519117C (en) * 2003-03-17 2010-03-02 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
CN101031290B (zh) * 2003-09-18 2011-09-21 赛福伦公司 改良释放的莫达非尼药物组合物
US8153159B2 (en) * 2003-09-18 2012-04-10 Cephalon, Inc. Modafinil modified release pharmaceutical compositions
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
JP2007533686A (ja) * 2004-04-22 2007-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 性的障害ｉｉ治療用の新規医薬組成物
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060024370A1 (en) 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
JP2008511569A (ja) * 2004-09-03 2008-04-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 注意欠如活動過多障害の治療方法
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006096435A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
JP2008540356A (ja) * 2005-05-06 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬物乱用の治療方法
CA2608363A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
JP2008540672A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 病状に起因する性的機能不全の治療方法
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
EP1945214A1 (en) * 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
CA2641917A1 (en) * 2006-02-18 2007-08-23 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
US20090312242A1 (en) * 2006-06-30 2009-12-17 Ramiro Castro Flibanserin for the treatment of urinary incontinence and related diseases
US20090318469A1 (en) * 2006-07-14 2009-12-24 Boehringer Ingelheim International Gmbh Use of Flibanserin for the Treatment of Sexual Disorders in Females
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
WO2008019996A2 (en) * 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
MX2009002031A (es) * 2006-08-25 2009-03-06 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo.
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
FR2987265B1 (fr) * 2012-02-28 2014-02-28 Debregeas Et Associes Pharma Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1570994A (en) * 1923-11-20 1926-01-26 William A Cook Spring-forming die
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
DE2927988A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 8-phenyl-purine, deren herstellung und deren verwendung als arzneimittel
US4431645A (en) * 1982-03-08 1984-02-14 Schering Corporation Antihypertensive agents
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4584285A (en) * 1983-06-02 1986-04-22 Schering Corporation Antihypertensive agents
US4710519A (en) * 1985-09-30 1987-12-01 Basf Corporation Process for preparing spray dried acetaminophen powder and the powder prepared thereby
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
TW272942B (cg-RX-API-DMAC7.html) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
FR2706767B1 (cg-RX-API-DMAC7.html) * 1993-06-22 1995-09-08 Lafon Labor
FR2707637B1 (fr) * 1993-06-30 1995-10-06 Lafon Labor Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
SI9500173B (sl) * 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
ZA97400B (en) * 1996-01-19 1997-11-13 Glaxo Group Ltd Valaciclovir.
JPH09208468A (ja) * 1996-02-02 1997-08-12 Dainippon Pharmaceut Co Ltd ｐ−クロロ−Ｎ−（２−モルホリノエチル）ベンズアミドを含有する錠剤
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
ES2364145T3 (es) * 1996-11-15 2011-08-25 Ajinomoto Co., Inc. Composición de nateglinida en comprimidos.
GB9714274D0 (en) * 1997-07-08 1997-09-10 Zeneca Ltd Pharmaceutical composition
US6599529B1 (en) 1997-09-11 2003-07-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs)
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
PT1140034E (pt) 1998-12-18 2004-03-31 Abbott Lab Formulacao de libertacao controlada de divalproex de sodio
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) * 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
US6204245B1 (en) * 1999-09-17 2001-03-20 The Regents Of The University Of California Treatment of narcolepsy with immunosuppressants
CN1249932A (zh) * 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
FR2804322B1 (fr) * 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
CZ306618B6 (cs) * 2000-10-11 2017-04-05 Cephalon, Inc. Kompozice obsahující sloučeniny modafinylu
US6489363B2 (en) * 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
SK287126B6 (sk) 2000-10-11 2009-12-07 Cephalon, Inc. Kompozície obsahujúce modafinilové zlúčeniny, spôsob ich prípravy a ich použitie
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
IL158959A (en) 2001-05-25 2010-06-30 Cephalon Inc Solid pharmaceutical formulations comprising modafinil
US7576133B2 (en) * 2002-03-11 2009-08-18 Carl Henry Lawyer Methods and compositions for nasal administration of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
AU2003249105A1 (en) 2002-07-08 2004-01-23 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
WO2004010979A1 (en) 2002-07-25 2004-02-05 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil

Similar Documents

Publication Publication Date Title
JP2006522006A5 (cg-RX-API-DMAC7.html)
US8512751B2 (en) Pharmaceutical compositions for sleep disorders
CA2182004C (en) Film coated tablet of paracetamol and domperidone
JP2007091758A5 (cg-RX-API-DMAC7.html)
JP2005515966A5 (cg-RX-API-DMAC7.html)
FI3457135T3 (fi) Fabryn taudin hoitovaihtoehtoja
JP2019505525A (ja) Ｊａｋキナーゼ阻害剤またはその薬剤的に許容される塩を含有する医薬組成物
JP2009500318A (ja) 新規な徐放性医薬組成物とその製法
JP2004532863A5 (cg-RX-API-DMAC7.html)
SE0104341D0 (sv) New use
JP2005530787A5 (cg-RX-API-DMAC7.html)
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
CA2448456A1 (en) Solid pharmaceutical formulations comprising modafinil
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
JP4041460B2 (ja) セチリジン及びプソイドエフェドリンを含む錠剤
EP3041511A2 (en) Compositions of eltrombopag
JP2020511419A5 (cg-RX-API-DMAC7.html)
CY1653A (en) Pharmaceutical compositions with analgesic properties and the preparation and use thereof
JP2004525940A5 (cg-RX-API-DMAC7.html)
KR100681360B1 (ko) 타액분비 촉진용 카르보스티릴 유도체
RU2005105302A (ru) Композиция бицифадина
JP2007529564A5 (cg-RX-API-DMAC7.html)
CN106822097A (zh) 一种用于减肥的含奥利司他的药物组合物
CN101756981B (zh) 一种布洛氯雷伪麻缓释制剂及其制备方法
CN106924270B (zh) 一种含有奥利司他的具有减肥功能的药物组合物